[18F]氟化钠PET有潜力识别局限性皮肤型系统性硬化症中钙质沉着症的活跃形成
本横断面观察性先导研究纳入9例符合2013年ACR/EULAR系统性硬化症(SSc)标准且临床可检出钙质沉着症的患者,采用全身[18F]氟化钠([18F]NaF)PET/低剂量CT(LDCT)评估活跃钙化的可视化可行性。结果显示[18F]NaF摄取多见于手指(n=7)和膝(n=5),3例患者手指[18F]NaF PET显示钙化而LDCT和临床未检出;97%的[18F]NaF阳性病灶可见于LDCT,LDCT可见病灶中70%同时[18F]NaF PET阳性。作者认为[18F]NaF PET/LDCT可检测活跃钙化形成,可能适用于早期疾病修饰干预,但需重复验证。
要点
- 9例SSc合并钙质沉着症患者中,[18F]NaF摄取多见于手指(n=7)和膝(n=5)。
- 3例患者手指[18F]NaF PET显示钙化,而LDCT和临床未检出。
- LDCT可见钙化中70%同时[18F]NaF PET阳性,97%的[18F]NaF阳性病灶可见于LDCT。
核心结论
- 使用[18F]NaF PET/LDCT对SSc中活跃钙化进行成像是可行的。
- LDCT上70%的钙化为[18F]NaF PET阳性。
- 尽管这些发现需要重复验证,[18F]NaF PET/LDCT或可检测活跃钙化形成,可能适用于早期疾病修饰干预。
研究设计与样本
- 横断面观察性先导研究,患者接受全身[18F]NaF PET/低剂量CT(LDCT)检查。
- 所有患者均符合2013年ACR/EULAR SSc标准,且临床可检出钙质沉着症。
- 共纳入9例女性患者,中位年龄59.0岁(IQR 51.5-70.5)。
- (亚)皮肤钙化由三名研究者描述。
主要发现
- [18F]NaF摄取多见于手指(n=7)和膝(n=5)。
- [18F]NaF PET在3例患者的手指显示钙化,而LDCT和临床未检出这些钙化。
- 97%的[18F]NaF阳性病灶可见于LDCT。
- 所有LDCT可见病灶中,70%也可见于[18F]NaF PET。
关键数值与推荐
- 所有患者均符合2013年ACR/EULAR SSc标准。
- 全部9例患者均有临床可检出的钙质沉着症。
- 共9例女性患者,中位年龄59.0岁(IQR 51.5-70.5)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 尽管这些发现需要重复验证,[18F]NaF PET/LDCT或可检测活跃钙化形成,可能适用于早期疾病修饰干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Calcinosis cutis affects 20-40% of patients with systemic sclerosis (SSc). When calcinosis cutis becomes clinically apparent, it is irreversible in most cases. Detection of active calcification formation might allow early disease-modifying interventions. We assessed the feasibility of visualizing active calcifications using [18F]Sodium Fluoride ([18F]NaF) PET/low-dose CT (LDCT) in SSc patients with calcinosis cutis. METHODS: In this cross-sectional, observational pilot study patients underwent a whole body [18F]NaF PET/LDCT. All patients met the 2013 ACR/EULAR SSc criteria and had clinically detectable calcinosis cutis. (Sub)cutaneous calcifications were described by three investigators. RESULTS: Nine female patients were included (median age 59.0 years [IQR 51.5-70.5]). [18F]NaF uptake was mostly visible in the fingers (n=7) and knees (n=5). [18F]NaF PET showed calcifications in the fingers of 3 patients where calcifications were undetected on LDCT and in the clinic. Ninety-seven percent of [18F]NaF positive lesions was visible on LDCT. Of all lesions visible on LDCT, 70% was also visible on [18F]NaF PET. CONCLUSION: Imaging of active calcifications in SSc is feasible using [18F]NaF PET/LDCT. Seventy percent of calcifications on LDCT were [18F]NaF PET positive. Although these findings require replication, [18F]NaF PET/LDCT may detect active calcification formation, being potentially suitable for early disease-modifying interventions.
引用
- Atzeni IM, Hogervorst EM, Stel AJ, et al. [18F]Sodium Fluoride PET has the potential to identify active formation of calcinosis cutis in limited cutaneous systemic sclerosis. Semin Arthritis Rheum. 2022. PMID: 35687922. doi:10.1016/j.semarthrit.2022.152027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。